RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/21308739http://www.w3.org/2000/01/rdf-schema#comment"In recent years many risk factors for the development of breast cancer that are linked to estrogens have been identified, and roscovitine (ROSC), a selective cyclin-dependent kinase (CDK) inhibitor, has been shown to be an efficient inhibitor of the proliferation of human breast cancer cells. Therefore, we have examined the possibility that interference with estrogen signaling pathways, using tamoxifen (TAM), a selective estrogen receptor modulator (SERM), could modulate the efficacy of treatment with ROSC. In conjunction with TAM, ROSC exhibited enhanced anti-proliferative activity and CDK inhibition, particularly in estrogen-dependent MCF-7 cells. The interaction between both drugs was synergistic. However, in ER-α-negative cells the interaction was antagonistic. Exposure of MCF-7 cells to ROSC abolished the activating phosphorylation of CDK2 and CDK7 at Ser(164/170). This in turn prevented the phosphorylation of the carboxyl-terminal repeat domain of RNA Polymerase II and ER-α at Ser(118), resulting in the down-regulation of the latter. Concomitantly, wt p53 was strongly activated by phosphorylation at Ser(46). Our results demonstrate that ROSC negatively affects the functional status of ER-α, making it potentially useful in the treatment of estrogen-dependent breast cancer cells."xsd:string
http://purl.uniprot.org/citations/21308739http://purl.org/dc/terms/identifier"doi:10.1002/jcb.23024"xsd:string
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/author"Maurer M."xsd:string
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/author"Komina O."xsd:string
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/author"Wesierska-Gadek J."xsd:string
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/author"Zulehner N."xsd:string
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/author"Gritsch D."xsd:string
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/date"2011"xsd:gYear
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/name"J Cell Biochem"xsd:string
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/pages"1103-1117"xsd:string
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/title"Interference with ER-alpha enhances the therapeutic efficacy of the selective CDK inhibitor roscovitine towards ER-positive breast cancer cells."xsd:string
http://purl.uniprot.org/citations/21308739http://purl.uniprot.org/core/volume"112"xsd:string
http://purl.uniprot.org/citations/21308739http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/21308739
http://purl.uniprot.org/citations/21308739http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/21308739
http://purl.uniprot.org/uniprot/#_A0A125SXW0-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739
http://purl.uniprot.org/uniprot/#_A0A125SXW1-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739
http://purl.uniprot.org/uniprot/#_Q14268-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739
http://purl.uniprot.org/uniprot/#_A0A125SXV8-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739
http://purl.uniprot.org/uniprot/#_A0A125SXV9-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739
http://purl.uniprot.org/uniprot/#_A0A125SXW2-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739
http://purl.uniprot.org/uniprot/#_A0A125SXW3-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739
http://purl.uniprot.org/uniprot/#_B6DU68-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739
http://purl.uniprot.org/uniprot/#_B6DU69-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739
http://purl.uniprot.org/uniprot/#_A0A125SXV6-mappedCitation-21308739http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/21308739